Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 29, 2002

View Archived Issues

Potential use of botulinum toxin A in the treatment of wrist spasticity following stroke

Enhanced p53-specific T-cell immunity found in colorectal cancer patients treated with ALVAC-p53

Potential use of LFM-A13 against chemotherapy-resistant B cell lymphomas or leukemias

FDA accepts MethyPatch NDA

Allos Therapeutics examines potential of RSR-13 in locally advanced cervical cancer

ISAtx-247 is a more effective immunosuppressant than ciclosporin in cynomolgus monkeys

Renal vasoconstriction induced by tacrolimus in rats is prevented by low dose theophylline

Selective inhibition of Rho-associated protein kinase attenuates hepatic ischemia/reperfusion injury

Effects of bimosiamose on renal preservation injury in a canine transplant model

EP4 selective agonists for treatment of skeletal disorders reported by Pfizer

Berlex reports a new series of CCR1 antagonists at the recent ACS meeting

Aerosol tacrolimus prevents acute pulmonary allograft rejection in a rat lung allograft model

Merck Frosst describes a new series of potent PDE4 inhibitors

Pivotal program protocol for T-67 approved by FDA

Crucell and Johns Hopkins sign cooperative agreement for antibodies against LCH

E.U. approval for Aranesp

MedImmune responds to Flumist complete response letter

Subanalysis of SnET2 phase III data

Dyax initiates phase I/II trial of DX-88 in cardiopulmonary bypass patients

Potent and selective MMP inhibitors designed at Pharmacia

Scientists at Genzyme identify novel compounds that modulate TNF-alpha signaling

Muscarinic M3 receptor antagonists disclosed by Almirall Prodesfarma

Farnesyl protein transferase-inhibiting compounds claimed by Janssen

PPAR modulators for use as hypoglycemics and lipid-lowering agents

DPP-IV inhibitors with utility in type 2 diabetes and associated complications

Daiichi Pharmaceutical prepares CDK4 inhibitors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...